Manual of Patent Examining Procedure - MPEP

Table of Contents


2400 Biotechnology

2400 Biotechnology
-    2401 Introduction
-    2402 The Deposit Rules
-    2403 Deposit of Biological Material
-    -    2403.01 Material Capable of Self- Replication
-    -    2403.02 Plant Material
-    2404 Need or Opportunity to Make a Deposit
-    -    2404.01 Biological Material That Is Known and Readily Available to the Public
-    -    2404.02 Biological Material That Can Be Made or Isolated Without Undue Experimentation
-    -    2404.03 Reference to a Deposit in the Specification
-    2405 Acceptable Depository
-    2406 Time of Making an Original Deposit
-    -    2406.01 Description in Application Specification
-    -    2406.02 Deposit After Filing Date - Corroboration
-    -    2406.03 Possible Loss of U.S. Filing Date in Other Countries
-    2407 Replacement or Supplement of Deposit
-    -    2407.01 In a Pending Application
-    -    2407.02 After a Patent Has Issued
-    -    2407.03 Failure to Replace
-    -    2407.04 Treatment of Replacement
-    -    2407.05 Exemption From Replacement
-    -    2407.06 Replacement May Not Be Recognized
-    2408 Term of Deposit
-    2409 Viability of Deposit
-    2410 Furnishing of Samples
-    -    2410.01 Conditions of Deposit
-    -    2410.02 Certification of Statement of Availability of Deposit
-    2411 Examination Procedures
-    -    2411.01 Rejections Based on Deposit Issue
-    -    2411.02 Replies to Rejections Based on Deposit Issue
-    -    2411.03 Application in Condition for Allowance Except for Deposit
-    -    2411.04 After a Patent Has Been Granted
-    -    2411.05 Content of Application with Respect to Deposited Material
-    2420 The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures - the Sequence Rules
-    2421 Overview of the Sequence Rules
-    -    2421.01 Applications Affected
-    -    2421.02 Summary of the Requirements of the Sequence Rules
-    -    2421.03 Notification of a Failure to Comply
-    -    2421.04 Future Changes to the Sequence Rules
-    2422 Nucleotide and/or Amino Acid Sequence Disclosures in Patent Applications
-    -    2422.01 Definitions of Nucleotide and/or Amino Acids for Purpose of Sequence Rules
-    -    2422.02 The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures
-    -    2422.03 The Requirements for a Sequence Listing and Sequence Identifiers; Sequences Embedded in Application Text; Variants of a Presented Sequence
-    -    2422.04 The Requirement for a Computer Readable Copy of the Official Copy of the Sequence Listing
-    -    2422.05 Reference to Previously Filed Identical Computer Readable Form; Continuing or Derivative Applications; Request for Transfer of Computer Readable Form
-    -    2422.06 Requirement for Statement Regarding Content of Official and Computer Readable Copies of Sequence Listing
-    -    2422.07 Requirements for Compliance, Statements Regarding New Matter, and Sanctions for Failure to Comply
-    -    2422.08 Presumptions Regarding Compliance
-    -    2422.09 Box Sequence; Hand Delivery of Sequence Listings and Computer Readable Forms
-    2423 Symbols and Format To Be Used for Nucleotide and/or Amino Acid Sequence Data
-    -    2423.01 Format and Symbols To Be Used in Sequence Listings
-    -    2423.02 Depiction of Coding Regions
-    -    2423.03 Presentation and Enumeration of Sequences
-    2424 Requirements for Nucleotide and/or Amino Acid Sequences as Part of the Application Papers
-    -    2424.01 Informational Requirements for the Sequence Listing
-    -    2424.02 Sequence Listing Numeric Identifiers
-    -    2424.03 Additional Miscellaneous Requirements
-    2425 Form and Format for Nucleotide and/or Amino Acid Sequence Submissions in Computer Readable Form
-    2426 Amendments to or Replacement of Sequence Listing and Computer Readable Copy Thereof
-    2427 Form Paragraphs and Notice to Comply
-    -    2427.01 Form Paragraphs
-    -    2427.02 Notice To Comply
-    2428 Sample Statements
-    2429 Helpful Hints for Compliance
-    2430 PatentIn Information; Utilities Programs; Training
-    2431 Sample Sequence Listing
-    2434 Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences
-    2435 Publishing of Patents and Patent Application Publications with Lengthy Sequence Listings

Next section